Holen Sie sich die Stockscreener-App
86.68
6.43%
5.24
Handel nachbörslich:
86.68
Irhythm Technologies Inc Aktie (IRTC) Neueste Nachrichten
IRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference - Marketscreener.com
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference - StockTitan
Director Abhijit Talwalkar Acquires 6,664 Shares of iRhythm Tech - GuruFocus.com
iRhythm Technologies, Inc. (NASDAQ:IRTC) CEO Sells $1,249,784.45 in Stock - MarketBeat
iRhythm Technologies, Inc. (NASDAQ:IRTC) Director Acquires $500,866.24 in Stock - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Stock Price Up 7.8%What's Next? - MarketBeat
iRhythm Technologies Inc (IRTC) Trading 4.41% Higher on Nov 4 - GuruFocus.com
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Purchased by Harbor Capital Advisors Inc. - MarketBeat
Emerging Opportunities in the Ecg Sensor Patch Market - openPR
Q1 EPS Forecast for iRhythm Technologies Raised by Analyst - MarketBeat
Trend Tracker for (IRTC) - Stock Traders Daily
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Earnings call: iRhythm Reports Growth Amid FDA Remediation Efforts By Investing.com - Investing.com Australia
iRhythm Leaders Concealed Heart Monitor Deficiencies, Suit Says - Bloomberg Law
FDA clears iRhythm’s second 510(k) in response to warning letter - MedTech Dive
iRhythm Technologies Third Quarter 2024 Earnings: EPS Misses Expectations - Simply Wall St
Here’s Why iRhythm Technologies (IRTC) Slid in Q3 - Insider Monkey
iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported, And Analysts Assigned A US$101 Price Target - Yahoo Canada Finance
iRhythm Technologies (NASDAQ:IRTC) Price Target Lowered to $79.00 at Robert W. Baird - MarketBeat
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q3 2024 Earnings Call Transcript - Insider Monkey
Stephens Investment Management Group LLC Has $29.72 Million Stock Position in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
iRhythm stock holds Buy as Needham adjusts target, highlights strong Zio AT momentum - Investing.com Australia
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - MSN
Earnings call: iRhythm Reports Growth Amid FDA Remediation Efforts - Investing.com
Forecasting The Future: 6 Analyst Projections For iRhythm Technologies - Benzinga
iRhythm Technologies (NASDAQ:IRTC) Posts Quarterly Earnings Results, Misses Estimates By $0.71 EPS - MarketBeat
iRhythm Technologies Gains FDA Clearance for Zio Design Changes - MPO-mag
iRhythm Technologies (NASDAQ:IRTC) Shares Gap Down on Disappointing Earnings - MarketBeat
FDA clears second set of changes to iRhythm Zio AT to resolve warning letter - Mass Device
Needham & Company LLC Cuts iRhythm Technologies (NASDAQ:IRTC) Price Target to $96.00 - MarketBeat
IRhythm Technologies (IRTC) Reports Q3 Loss, Tops Revenue Estimates - MSN
iRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
iRhythm Technologies Inc (IRTC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
FDA clears iRhythm's Zio AT device enhancements for 2025 By Investing.com - Investing.com Canada
FDA clears iRhythm's Zio AT device enhancements for 2025 - Investing.com India
iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device - The Manila Times
iRhythm Technologies (IRTC) Receives FDA 510(k) Clearance for Design Modifications to Its Zio AT Device - StreetInsider.com
iRhythm Technologies Announces Third Quarter 2024 Financial Results - The Manila Times
Earnings Preview For iRhythm Technologies - Benzinga
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy - The Manila Times
Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio? - Benzinga
iRhythm shares soar after FDA clears Zio AT device updates - MSN
IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc.IRTC - Business Wire
iRhythm’s Zio AT design changes win FDA clearance - MedTech Dive
iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock? - MSN
iRhythm Technologies (IRTC) to Release Quarterly Earnings on Wednesday - MarketBeat
BTIG bullish on iRhythm stock, FDA clearance partially lifts regulatory overhang - Investing.com Canada
iRhythm Technologies, Inc. (NASDAQ:IRTC) Stock Position Raised by Allspring Global Investments Holdings LLC - MarketBeat
Truist raises iRhythm stock target, keeps at Buy list on FDA approval By Investing.com - Investing.com South Africa
Truist raises iRhythm stock target, keeps at Buy list on FDA approval - Investing.com Nigeria
iRhythm Technologies: Today's 510(K) Victory May Only Be A Temporary Reprieve - Seeking Alpha
IRhythm Earns FDA Nod For Zio AT After Warning Letter - MPO-mag
How to Take Advantage of moves in (IRTC) - Stock Traders Daily
iRhythm Technologies (NASDAQ:IRTC) Price Target Raised to $95.00 - MarketBeat
Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday - MSN
0.47%
1.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):